The article 'MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2' [Cell Physiol Biochem 2017;44:1785-1795. DOI: 10.1159/000485785] by Zhi-Dong Lv, Dong-Xia Yang, Xiang-Ping Liu, Li-Ying Jin, Xin-Gang Wang, Zhao-Chuan Yang, Dong Liu, Jiao-Jiao Zhao, Bin Kong, Fu-Nian Li, and Hai-Bo Wang has been retracted by the current and former Publishers and the Editor on behalf of the authors.
After publication of this article, concerns were raised about the integrity of some of the data presented. Specifically, areas of Figure 3A appear to have similarity to Figure 4D from another publication [Lv. et al 2016] in three instances. In addition, elements of Figure 3, 5 and 7 in this article appear to be presented in other articles without justification. When asked to comment on the above, the corresponding author stated that errors were made in the preparation of the figures. The authors stated that the conclusions of the article are considered to be invalid, and the authors requested retraction of the article. As the concerns raised about the figures cannot be addressed, the article has been retracted.
Lv, Z.-D., Yang, Z.-C., Liu, X.-P., Jin, L.-Y., Dong, Q., Qu, H.-L., Li, F.-N., Kong, B., Sun, J., Zhao, J.-J. and Wang, H.-B. (2016), Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple-negative breast cancer. J. Cell. Mol. Med., 20: 1640-1650. https://doi.org/10.1111/jcmm.12856